{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:14:00Z","timestamp":1789913640118,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.11.075","type":"journal-article","created":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T04:32:01Z","timestamp":1260851521000},"page":"1881-1886","source":"Crossref","is-referenced-by-count":28,"title":["Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Meddeb-Garnaoui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Toumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ghelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mahjoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Louzir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chenik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.11.075_bib1","unstructured":"WHO Leishmaniasis: background information. Available at: http:\/\/www.whoint\/leishmaniasis\/en\/2009."},{"issue":"October (5)","key":"10.1016\/j.vaccine.2009.11.075_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ije\/dym125","article-title":"Zoonotic cutaneous leishmaniasis in central Tunisia: spatio temporal dynamics","volume":"36","author":"Salah","year":"2007","journal-title":"Int J Epidemiol"},{"issue":"May (9115)","key":"10.1016\/j.vaccine.2009.11.075_bib3","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran","volume":"351","author":"Sharifi","year":"1998","journal-title":"Lancet"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2009.11.075_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","volume":"180","author":"Lira","year":"1999","journal-title":"J Infect Dis"},{"issue":"November (9241)","key":"10.1016\/j.vaccine.2009.11.075_bib5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"Khalil","year":"2000","journal-title":"Lancet"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.11.075_bib6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"July\u2013September (3)","key":"10.1016\/j.vaccine.2009.11.075_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/039463200702000302","article-title":"Immunopathology of leishmaniasis: an update","volume":"20","author":"Mansueto","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"January (1\u20132)","key":"10.1016\/j.vaccine.2009.11.075_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2478(98)00132-1","article-title":"T-cell response in human leishmaniasis","volume":"65","author":"Kharazmi","year":"1999","journal-title":"Immunol Lett"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.11.075_bib9","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1128\/IAI.68.4.1760-1764.2000","article-title":"Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection","volume":"68","author":"Ajdary","year":"2000","journal-title":"Infect Immun"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.11.075_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4269\/ajtmh.1995.53.273","article-title":"Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis","volume":"53","author":"Carvalho","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2009.11.075_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2249.1999.00844.x","article-title":"Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia","volume":"116","author":"Sassi","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.11.075_bib12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.166.1.498","article-title":"Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning","volume":"166","author":"Probst","year":"2001","journal-title":"J Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.11.075_bib13","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease","volume":"69","author":"Campos-Neto","year":"2001","journal-title":"Infect Immun"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2009.11.075_bib14","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J Exp Med"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.11.075_bib15","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect Immun"},{"issue":"October (9185)","key":"10.1016\/j.vaccine.2009.11.075_bib16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"issue":"January\u2013March (1)","key":"10.1016\/j.vaccine.2009.11.075_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/0022-3859.927","article-title":"Recent advances in the diagnosis of leishmaniasis","volume":"49","author":"Singh","year":"2003","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.vaccine.2009.11.075_bib18","first-page":"195","article-title":"Diagnosis and treatment of Indian visceral leishmaniasis","volume":"February (51)","author":"Sundar","year":"2003","journal-title":"J Assoc Physicians India"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.11.075_bib19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.trstmh.2007.11.004","article-title":"Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis","volume":"102","author":"Pedras","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.11.075_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-3156.2005.01533.x","article-title":"Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal","volume":"11","author":"Chappuis","year":"2006","journal-title":"Trop Med Int Health"},{"issue":"November (1\u20132)","key":"10.1016\/j.vaccine.2009.11.075_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s004300100083","article-title":"Development and application of \u2018simple\u2019 diagnostic tools for visceral leishmaniasis","volume":"190","author":"Schallig","year":"2001","journal-title":"Med Microbiol Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.11.075_bib22","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4269\/ajtmh.2003.68.312","article-title":"Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis","volume":"68","author":"Maalej","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.11.075_bib23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/infdis\/173.3.758","article-title":"rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis","volume":"173","author":"Badaro","year":"1996","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.11.075_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1365-3156.2001.00680.x","article-title":"Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan","volume":"6","author":"Zijlstra","year":"2001","journal-title":"Trop Med Int Health"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.11.075_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4269\/ajtmh.2008.79.76","article-title":"Evaluation of direct agglutination test, rk39 Test, and ELISA for the diagnosis of visceral leishmaniasis","volume":"79","author":"Mandal","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2009.11.075_bib26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.d01-865.x","article-title":"Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis","volume":"106","author":"Soto","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.11.075_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1365-2249.1999.00796.x","article-title":"Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis","volume":"115","author":"Soto","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"March (14)","key":"10.1016\/j.vaccine.2009.11.075_bib28","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.vaccine.2005.12.027","article-title":"Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB\/c mice against a virulent challenge with Leishmania major","volume":"24","author":"Chenik","year":"2006","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.11.075_bib29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0169-4758(00)01651-3","article-title":"Evolutionarily conserved proteins as prominent immunogens during Leishmania infections","volume":"16","author":"Requena","year":"2000","journal-title":"Parasitol Today"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2009.11.075_bib30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0035-9203(97)90520-4","article-title":"Recombinant antigens for specific and sensitive serodiagnosis of Latin American tegumentary leishmaniasis","volume":"91","author":"Montoya","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"December (3)","key":"10.1016\/j.vaccine.2009.11.075_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0165-2478(95)02473-5","article-title":"Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis","volume":"48","author":"Soto","year":"1995","journal-title":"Immunol Lett"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.11.075_bib32","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1128\/IAI.68.10.5595-5602.2000","article-title":"Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library","volume":"68","author":"Melby","year":"2000","journal-title":"Infect Immun"},{"issue":"September (29\u201330)","key":"10.1016\/j.vaccine.2009.11.075_bib33","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.vaccine.2004.04.015","article-title":"Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis","volume":"22","author":"Iborra","year":"2004","journal-title":"Vaccine"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2009.11.075_bib34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.vaccine.2007.12.051","article-title":"Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines","volume":"26","author":"Carrion","year":"2008","journal-title":"Vaccine"},{"issue":"March\u2013April (2)","key":"10.1016\/j.vaccine.2009.11.075_bib35","first-page":"115","article-title":"Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity","volume":"17","author":"Von Stebut","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.11.075_bib36","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20061886","article-title":"CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis","volume":"204","author":"Anderson","year":"2007","journal-title":"J Exp Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.11.075_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/CVI.00023-09","article-title":"Cellular and humoral responses to Leishmania major virulence factors in healed cutaneous leishmaniasis and Mediterranean visceral leishmaniasis patients","volume":"16","author":"Lakhal-Naouar","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.11.075_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1286-4579(02)00051-5","article-title":"Characterization of the immune response to Leishmania infantum recombinant antigens","volume":"5","author":"de Carvalho","year":"2003","journal-title":"Microbes Infect"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.11.075_bib39","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.0300-9475.2004.01388.x","article-title":"Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors","volume":"59","author":"Nylen","year":"2004","journal-title":"Scand J Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.11.075_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2249.2008.03705.x","article-title":"Contrasting human cytokine responses to promastigote whole-cell extract and the Leishmania analogue receptor for activated C kinase antigen of L. amazonensis in natural infection versus immunization","volume":"153","author":"Azeredo-Coutinho","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.11.075_bib41","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/IAI.60.7.2688-2693.1992","article-title":"Mapping of a visceral leishmaniasis-specific immunodominant B-cell epitope of Leishmania donovani Hsp70","volume":"60","author":"Wallace","year":"1992","journal-title":"Infect Immun"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2009.11.075_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-2478(95)02436-0","article-title":"Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis","volume":"48","author":"Soto","year":"1995","journal-title":"Immunol Lett"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T03:39:49Z","timestamp":1590291589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09018829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09018829"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}